14 April 2026
GLP-1 weight loss medications are gaining traction in South Africa. Discover their potential impact on healthcare and FMCG trends.
8 January 2026
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
6 January 2026
Illegal weight loss injections are flooding the local market as high costs and obesity rates drive a dangerous market for GLP-1 agonists.
15 October 2025
Aspen shares soar following the approval of Mounjaro for weight loss in South Africa. Discover the impact on obesity management.
11 September 2025
26 August 2025
Find out how GLP-1 drugs like Ozempic and Wegovy can lower cancer risk while aiding in weight loss and diabetes control.
22 August 2025
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.
29 June 2025
Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.
29 June 2025
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
28 October 2024
Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.